Polar Asset Management Partners Inc. Purchases Shares of 84,400 OrthoPediatrics Corp. (NASDAQ:KIDS)

Polar Asset Management Partners Inc. acquired a new position in shares of OrthoPediatrics Corp. (NASDAQ:KIDS) in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund acquired 84,400 shares of the company’s stock, valued at approximately $2,288,000. Polar Asset Management Partners Inc. owned 0.35% of OrthoPediatrics at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in the business. Vanguard Group Inc. increased its stake in OrthoPediatrics by 1.3% during the 1st quarter. Vanguard Group Inc. now owns 883,827 shares of the company’s stock valued at $25,772,000 after buying an additional 11,100 shares during the period. Portolan Capital Management LLC increased its stake in shares of OrthoPediatrics by 66.2% during the third quarter. Portolan Capital Management LLC now owns 308,099 shares of the company’s stock valued at $8,353,000 after acquiring an additional 122,770 shares during the period. Harbor Capital Advisors Inc. increased its stake in shares of OrthoPediatrics by 268.1% during the third quarter. Harbor Capital Advisors Inc. now owns 246,860 shares of the company’s stock valued at $6,692,000 after acquiring an additional 179,803 shares during the period. Paradigm Capital Management Inc. NY raised its holdings in OrthoPediatrics by 8.0% during the second quarter. Paradigm Capital Management Inc. NY now owns 134,400 shares of the company’s stock worth $3,865,000 after purchasing an additional 10,000 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. lifted its position in OrthoPediatrics by 2.1% in the third quarter. Charles Schwab Investment Management Inc. now owns 132,434 shares of the company’s stock worth $3,590,000 after purchasing an additional 2,661 shares during the period. 69.05% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

A number of research firms have recently commented on KIDS. JMP Securities reissued a “market outperform” rating and issued a $50.00 price objective on shares of OrthoPediatrics in a research note on Friday, September 13th. Truist Financial dropped their price target on shares of OrthoPediatrics from $34.00 to $28.00 and set a “hold” rating on the stock in a research report on Monday, October 14th. Finally, Needham & Company LLC restated a “buy” rating and set a $42.00 price objective on shares of OrthoPediatrics in a research report on Friday, November 8th.

OrthoPediatrics Trading Down 5.3 %

OrthoPediatrics stock opened at $23.10 on Friday. OrthoPediatrics Corp. has a 1 year low of $22.41 and a 1 year high of $36.23. The firm’s 50 day moving average price is $25.89 and its two-hundred day moving average price is $28.93. The firm has a market cap of $559.48 million, a price-to-earnings ratio of -18.78 and a beta of 1.14. The company has a debt-to-equity ratio of 0.19, a quick ratio of 3.68 and a current ratio of 7.17.

OrthoPediatrics Profile

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.